Abstract
Introduction Surgical resection is the best treatment option for hepatic metastases (HM) from colorectal carcinoma (CRC) and can be of benefit to patients with HM from neuroendocrine tumours. However, the benefit of hepatic resection in patients with HM resulting from non-colorectal non-neuroendocrine (NCRCNNE) tumours has not been established. The aim is to review our experience of hepatic resection in the treatment of these tumours and to evaluate the benefit with respect to survival and recurrence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
